Many companies are being hurt by social distancing safety rules due to the coronavirus and investors may want to reevaluate whether to own their stocks, CNBC’s Jim Cramer said Tuesday. “Social distancing is going to be the answer why you have to sell certain stocks,” Cramer said. For companies that need to invest heavily to help
0 Comments
U.S. President Donald Trump speaks to reporters as Senator Roy Blunt (R-MO) and Small Business Administration (SBA) Administrator Jovita Carranza look on during a signing ceremony for the “Paycheck Protection Program and Health Care Enhancement Act,” approving additional coronavirus disease (COVID-19) relief for the U.S. economy and hospitals treating people sickened by the pandemic, in
0 Comments
As many states are re-opening for business, sobering estimates about the potential spread of Covid-19 in the U.S. are emerging. An interagency report from the U.S. departments of Homeland Security, and Health and Human Services projected the number of coronavirus deaths will increase to about 3,000 each day by early June. The analysis also reportedly
0 Comments
Niraj Shah, CEO, Wayfair Ashlee Espinal | CNBC Online furniture retailer Wayfair‘s net loss widened in the first quarter as its sales surged nearly 20%, with more people flocking to its website to furnish their home offices and bedrooms during the coronavirus pandemic.  Its shares were down more than 3% in premarket trading following the announcement.  Here’s
0 Comments
CNBC’s Jim Cramer said Monday that legendary investor Warren Buffett gave “no hope near term” in his annual shareholders meeting on Saturday with his sale of airline stocks. “Buffett’s overview on airlines really does make me very concerned about the near term,” Cramer said on “Squawk on the Street.”  The billionaire investor said Saturday that
0 Comments
Pharmaceutical companies continue to make headlines as governments and investors hang their hopes on a steady recovery from the Covid-19 pandemic. Gilead Sciences CEO Daniel O’Day said Sunday the company would be donating its entire supply of remdesivir to treat coronavirus patients. Roche Chairman Christoph Franz said the drugmaker will invest more than $437 million in a
0 Comments